Searchable abstracts of presentations at key conferences in endocrinology

ea0021p389 | Thyroid | SFEBES2009

TSH receptor antibody assay: its use in a tertiary centre

Theodoraki Aikaterini , Jones Gareth L , Perera Sithara , Patel Darshna , Parker Jennifer C , Bunn Chris C , Thomas Mike , Bouloux Pierre-Mark , Vanderpump Mark

Background: The BTA guidelines for the use of thyroid function tests recommend the measurement of TSH receptor antibodies (TRAb) when investigating hyperthyroidism of uncertain aetiology, in suspected Graves’ ophthalmopathy and in pregnant women with Graves’ disease. An in-house TSH receptor autoantibody ELISA assay (TRAb) was introduced in 2008. This study has audited the assay performance and evaluated its clinical usefulness in a tertiary centre.<p class="abst...

ea0077oc5.4 | Bone and Calcium | SFEBES2021

Nuclear factor I/X (NFIX) regulates the transcriptional activity of the cellular retinoic acid binding protein 2 (CRABP2) promoter and alters CRABP2 expression in Marshall-Smith Syndrome (MSS) patients.

Kooblall Kreepa , Stevenson Mark , Lines Kate , Stewart Michelle , Wells Sara , Teboul Lydia , Hennekam Raoul , Thakker Rajesh

Marshall-Smith syndrome (MSS) is a congenital disorder affecting skeletal and neural development, due to mutations in the nuclear factor I/X (NFIX) gene. NFIX encodes a ubiquitously expressed transcription factor that regulates the expression of viral and cellular genes. To identify novel genes that are misregulated by NFIX mutations, RNA sequencing and proteomics analyses were performed on mouse embryonic fibroblast (MEF) cells derived from a repres...

ea0077p135 | Adrenal and Cardiovascular | SFEBES2021

Undetectably low blood aldosterone concentrations are prevalent in COVID-19 patients but poorly quantified by chemiluminescent immunoassay

Halsall David , Wiegard Martin , Goudie Robert , Taylor Kevin , Cowan Sarah , Prellor Jacobus , Gurnell Mark

Background: SARS-CoV-2 targets membrane-bound angiotensin-converting enzyme 2 (ACE2) to achieve cellular entry. Resultant loss of ACE2 function may lead to unregulated activation of the renin-angiotensin-aldosterone system (RAAS), contributing to the pathogenesis of hypertension and triggering a proinflammatory cascade. However, evidence to support this is conflicting, with either no change or an increase in the concentration of circulating aldosterone reported in patients wit...

ea0077p172 | Metabolism, Obesity and Diabetes | SFEBES2021

ATP-Binding Cassette Subfamily C Member 1 (ABCC1) influences adiposity, glucose homeostasis and insulin sensitivity

Villalobos Elisa , Chua EE June , Miguelez-Crespo Allende , Morgan Ruth , Andrew Ruth , Nixon Mark , Walker Brian

Background: Glucocorticoids (GCs) modulate glucose homeostasis by acting on metabolic tissues including liver, adipose, and skeletal muscle. ABCC1 is a transmembrane ‘drug-resistance’ transporter expressed in adipose tissue and skeletal muscle with previously unknown physiological function. We recently showed that ABCC1 modulates intracellular GC concentrations and action in adipose. Here, we tested the hypothesis that Abcc1 regulates GC concentrations in skeletal mu...

ea0077p184 | Metabolism, Obesity and Diabetes | SFEBES2021

Does human serum impact differentiation and mitochondrial function of human LHCN-M2 skeletal muscle cells?

Turner Mark , Saini Amarjit , Brown Holly , Anisi Sara , Stewart Claire , Renshaw Derek

Introduction: Skeletal muscle cells enable investigation of myogenesis and metabolic function in vitro. Exposure to human serum can provide insight into the impact of endocrine factors upon differentiation and mitochondrial function of skeletal muscle. The aim of these experiments was to optimise the culture conditions using human serum, which it was hypothesised would enhance myogenesis and mitochondrial function of LHCN-M2 human skeletal muscle cells.<p class="a...

ea0078OC6.5 | Oral Communications 6 | BSPED2021

Highlighting POLE1 mutations as a cause of adrenal insufficiency

Dhamodaran Madhuvanthi , Dyke Mark , Walston Florence , Booth David , Andrews Katrina , Armstrong Ruth , Webb Emma

Background: Compound heterozygous POLE1 mutations have previously been described as a cause of IMAGe syndrome. The severity of the adrenal insufficiency (AI) at initial presentation has been a subject of ongoing debate. Case report: At 22 weeks gestation the proband’s mother was referred to paediatric endocrinology for low oestriol on antenatal quadruple testing. The pregnancy was complicated by severe growth restriction leading to emergency caesare...

ea0078OC8.1 | Oral Communications 8 | BSPED2021

Cystic fibrosis related diabetes (CFRD): could Cystic Fibrosis Transport Receptor (CFTR) modulators be the answer?

Park Julie , Walsh Anna , Kerr Sue , Woodland Clare , Southward Suzanne , Deakin Mark , Thursfield Rebecca , Senniappan Senthil

Background: Cystic Fibrosis related diabetes affects 40-50% of adults with cystic fibrosis (CF). This can significantly affect pulmonary function and life expectancy. Kaftrio (Ivakaftor, tezacaftor and elexacaftor) has recently been licensed for use in CF. Previous data highlight that glucose regulation may be altered on commencing this treatment.Methods: Eight children and young people (CYP), aged 14 (12-15) years, who were diagnosed with CFRD aged 12.8...

ea0054p7 | (1) | NuclearReceptors2018

MIR-96 regulates retinoic acid receptor gamma cross-talk with the androgen receptor to drive aggressive prostate cancer

Long Mark D , Rosario Spencer , Sucheston-Campbell Lara E , Smiraglia Dominic J , Campbell Moray J

The retinoic acid receptor gamma (RARg, encoded by NR1B3/RARG) is significantly downregulated but not mutated in the MSKCC and PRAD prostate cancer (PCa) cohorts in the Cancer Genome Atlas (TCGA) data. We investigated the consequences of modifying RARg expression.Independent of ligand, stable RARg knockdown stimulated RWPE-1 and LNCaP cells proliferation, changed the cell cycle profile and significantly altered global gene expression patterns th...

ea0052p04 | (1) | UKINETS2017

A liquid biopsy for the diagnosis and monitoring of bronchopulmonary/lung carcinoid

Modlin Irvin M , Kidd Mark , Drozdov Ignat , Aslanian Harry , Bodei Lisa , Matar Somer , Chung Kjung-Min

Background: No effective blood biomarker exists to detect and clinically manage bronchopulmonary (BP) neuroendocrine tumors. We developed a blood-based 51 neuroendocrine tumor (NET)-specific transcript set to diagnose and monitor gastroenteropancreatic NETs. In this study, we examined whether the signature functioned in lung NETs. Thereafter, we examined performance metrics to assess clinical utility. The multianalyte gene signature accurately diagnosed the tumor and in additi...

ea0052p06 | (1) | UKINETS2017

Nutritional assessment and vitamin deficiencies in patients with NETs

Lim Sheryl , Reynolds Mark , Chaudhry Rayhan , Blackhouse Jennifer , Rees Aled , Khan Mohid

Introduction: Neuroendocrine tumours (NETs) have diverse natural history and clinical syndromes. As a result of the disease or related to management, patients may have altered gut or pancreatic function that can cause nutritional deficiencies. There is a lack of consistent evidence-based dietetic guidance for patients with NETs.Aim: This study evaluated whether nutritional status and nutritional deficiencies had been assessed in patients with NETs in an ...